如果您期望与亚洲生物制药领域的决策者们会面及交流学习，这里将是您唯一正确的选择。令您及您的团队始终处于亚洲生物制药发展最前沿，尽在2019年9月10-11日的第四届生物制药创新国际峰会，期待您的参与！
届时峰会将有国际主题演讲，产业及学术报告，众多交流机会，将为高端科技及商业探讨打造一个互动的平台。我们欢迎阁下致电我们86-21-31602153或86 13661829149获取更多信息，请登录我们的会议网站www.bioinnovationforum.com 或把您的问题发送至我们电邮marketing@wbfgroup.com 。
Event Name: The 4th Annual Biopharma Innovation Conference 2019
Date:September 10th to 11th,2019
Venue: Wyndham Bund East Shanghai,China
Contact Person:Marketing Department
Direct Line:86 21 31602153
Mobille:86 13661829149
Email:Marketing@wbfgroup.com
Website: www.bioinnovationforum.com
The 4th Annual Biopharma Innovation Conference 2019
about ABIC 2019
As the BioPharma industry grows in China & the Asian region. A part of our highly successful Biopharma series, the event, which attracts over 300 attendees, is the leading industry platform for Biopharma, biotech, Manufacturing Equipments, Bioscience and Analytical Equipments,Facility Design, Cold Chain, CMOs, CROs, Research institutes, investors,Technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China.
Covering topics ranging from latest regulations impacting to International partnering;from Biopharma R&D and Biotechnology to Biosimilar Development,from CMO and CRO,from Antibody development to Clinical Trials,from Biomanufacturing to Bioprocessing; from Upsteam: Cell Culture and Cell Line Development to Downstream: Production, Purification&Filtration,from Analytical and Protein engineering technology to expression & Characterization; From AI and Smart to Automation and Digitalization, from Cutting edge technology & solutions to best Practice case studies;from business strategy, investment to innovation.
This is probably the most important event in the year on biopharma in terms of participants. It cannot be missed.
With over 40 speakers and estimation to bring over 300 Biopharma professionals, the key congress topics will cover:
• New investment and outlook in china biopharma industry, Biotech Innovation and regulatory compliance
• Round-table Discussions on Catering the Industry’s Challenges and Opportunities to Asia’s Landscape
• Global Biopharma R&D Strategy Perspective,Antibody development，Clinical Design of Innovative Biopharma
• Design and Engineering Improvement of Bispecific Antibodies and ADCs for druggability
• CFDAs priority review policy and impact on biosimilars，The current clinical trial landscape for new biosimilars, and expected pipelines
• Innovation and technology breakthroughs for Biosimilar development，Discuss the advanced strategy and solutions to enhance biosimilars’bioprocessing stability and reliability
• Market outlook for cell lines develoment across drug discovery, bioproduction, toxicity testing, and tissue engineering
• The growing use of reagents and media, and technical best practice,Cell Culture and Purification Process Development Strategy from Analytical Approach
• Clinical and commercial phase market outlook for CMOs in China,Antibody Continuous Process Scale-up
• Analytical Characterization Strategies, Technology & Product Comparability，Leading Protein and Antibody Engineering Technology and Innovational Application
• Advances in Upstream & Downstream Processing，Next Generation Bioprocessing, Global Updates on Manufacturing Technologies ，Facility Design & Engineering Case Studies
• Automation and Digitalisation Trends ，AI in Biomanufacturing
On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Biopharma industry in Asia
Who should attend?
More than 300 participants are expected to attend “The 4th Annual Biopharma Innovation Conference 2019, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:
By Job Title:
Chief Executives, Scientists, Directors, General
Managers and Heads of:
• Antibody Research and Development
• Antibody Technology
• Immunology
• Cancer / Autoimmune Research
• Biopharmaceutical Research
• Bio-analytical science
• Regulatory affairs
• Preclinical/clinical research and development
• Biosimilars
• Licensing
• Business Development
• Antibody Purification
• Chief technology
• Process development
• Manufacturing
• External manufacturing/manufacturing network
• Quality assurance/quality control
• Technical operations
• Cell culture
By Industry:
·Biopharmaceutical Companies
·Vaccine/Antibody Companies
·Biotech Companies
·Generics
• Manufacturing solution providers (upstream,downstream)
·Bioscience and Analytical Equipments
·Diagnostic and Testing Equipments
·Facility Design
·Protein Drug Companies
• Contract service providers (CROs, CMOs,CDMOs)
• Facility HVAC, cleanroom and containment equipment providers
• Country governments / trade agencies
·Lab Equipment Suppliers
• Legal and compliance firms
• 3rd party logistics providers
• Cold chain packaging companies
• Distributors in Asia Pacifi c
• Executive search firms
• Laboratory equipment providers
• Bio Parks
Who Should Sponsor?
• Contract Manufacturing Organizations
• Contract Research Organizations
• Cell Culture and Media / Cell Lines Solutions Provider
• Disposable Technology Providers
• Purification Technology Providers
• Bioprocess Technology Providers
• Automation Technology Providers
• Process Analytical Technology (PTA) Providers
• Consultants in Process and Plant Design
• Construction and Engineering Services
• Equipment Providers
• Biologics Technology Platforms/Biotechs
• Distribution and Logistics
• Cold Chain Storage
• Regional Development Agencies
• Reagent Providers
• Packaging, Fill and Finish Service Providers
• Consultants (Law, Auditing)
联系方式
联系人：Marketing Department
电话：86 21 31602153
Email：Marketing@wbfgroup.com
我要评论
所有评论仅代表网友意见，与本站立场无关。